simulating dissolution data beyond observed lab data [Dissolution / BCS / IVIVC]

posted by dshah  – India, 2024-06-10 11:10 (335 d 20:44 ago) – Posting: # 24027
Views: 2,178

Hi Achievwin,

I agree with Helmut's input.
Further- the assumptions used for extrapolation of modeling, the function/model used used for extrapolation, limitation of used model can be considered on a brief.
Generally, dissolution condition which can fasten the rate of release can be tried for e.g. increasing temperature, rpm, change over media, etc. so that it can be confirmed that the drug release is complete.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
148 visitors (0 registered, 148 guests [including 6 identified bots]).
Forum time: 07:55 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5